Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pepgen Inc. (PEPG) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pepgen Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1835597.
Total stock buying since 2022: $71,041,903.
Total stock sales since 2022: $1,660,687.
Total stock option exercises since 2022: $664,723.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 59,875 | $71,667 | 2,959 | $4,970 | 0 | $0 |
| 2024 | 2,557,593 | $27,212,789 | 60,000 | $1,039,789 | 50,000 | $510,495 |
| 2023 | 1,694 | $7,055 | 37,642 | $615,928 | 37,642 | $154,228 |
| 2022 | 3,645,866 | $43,750,392 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 8,375 | $10,393 | 0 | $0 | 0 | $0 |
| 2025-04 | 51,500 | $61,274 | 0 | $0 | 0 | $0 |
| 2025-02 | 0 | $0 | 2,959 | $4,970 | 0 | $0 |
| 2024-07 | 0 | $0 | 30,498 | $552,163 | 30,498 | $311,381 |
| 2024-06 | 0 | $0 | 19,502 | $353,526 | 19,502 | $199,114 |
| 2024-05 | 0 | $0 | 10,000 | $134,100 | 0 | $0 |
| 2024-02 | 2,557,593 | $27,212,789 | 0 | $0 | 0 | $0 |
| 2023-11 | 1,694 | $7,055 | 0 | $0 | 0 | $0 |
| 2023-06 | 0 | $0 | 31,250 | $505,361 | 31,250 | $84,686 |
| 2023-03 | 0 | $0 | 392 | $7,840 | 392 | $4,264 |
| 2023-02 | 0 | $0 | 6,000 | $102,727 | 6,000 | $65,278 |
| 2022-05 | 3,645,866 | $43,750,392 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-30 | Streck Paul (EVP, Head of R&D) | Buy | 8,375 | 1.24 | 10,393 |
| 2025-04-17 | Mcarthur James G (President and CEO) | Buy | 10,000 | 1.35 | 13,550 |
| 2025-04-08 | Mcarthur James G (President and CEO) | Buy | 41,500 | 1.15 | 47,724 |
| 2025-02-26 | Donnelly Noel (Chief Financial Officer) | Sale | 1,527 | 1.68 | 2,565 |
| 2025-02-26 | Delena Mary Beth (General Counsel) | Sale | 1,432 | 1.68 | 2,405 |
| 2024-07-25 | Mellion Michelle L (Chief Medical Officer) | Sale | 7,571 | 18.06 | 136,739 |
| 2024-07-25 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 7,571 | 10.21 | 77,299 |
| 2024-07-24 | Mellion Michelle L (Chief Medical Officer) | Sale | 201 | 18.00 | 3,619 |
| 2024-07-24 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 201 | 10.21 | 2,052 |
| 2024-07-18 | Mellion Michelle L (Chief Medical Officer) | Sale | 12,625 | 18.20 | 229,800 |
| 2024-07-18 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 12,625 | 10.21 | 128,901 |
| 2024-07-16 | Mellion Michelle L (Chief Medical Officer) | Sale | 5,901 | 18.00 | 106,247 |
| 2024-07-16 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 5,901 | 10.21 | 60,249 |
| 2024-07-12 | Mellion Michelle L (Chief Medical Officer) | Sale | 3,288 | 18.05 | 59,331 |
| 2024-07-12 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 3,288 | 10.21 | 33,570 |
| 2024-07-02 | Mellion Michelle L (Chief Medical Officer) | Sale | 37 | 18.07 | 668 |
| 2024-07-02 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 37 | 10.21 | 377 |
| 2024-07-01 | Mellion Michelle L (Chief Medical Officer) | Sale | 875 | 18.01 | 15,759 |
| 2024-07-01 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 875 | 10.21 | 8,933 |
| 2024-06-24 | Mellion Michelle L (Chief Medical Officer) | Sale | 9,260 | 18.19 | 168,430 |
| 2024-06-24 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 9,260 | 10.21 | 94,544 |
| 2024-06-12 | Mellion Michelle L (Chief Medical Officer) | Sale | 1,086 | 18.06 | 19,614 |
| 2024-06-12 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 1,086 | 10.21 | 11,088 |
| 2024-06-11 | Mellion Michelle L (Chief Medical Officer) | Sale | 500 | 18.04 | 9,022 |
| 2024-06-11 | Mellion Michelle L (Chief Medical Officer) | Option Ex | 500 | 10.21 | 5,105 |
| 2024-06-06 | Mellion Michelle L (SVP, Clinical Development) | Sale | 1,411 | 18.00 | 25,398 |
| 2024-06-06 | Mellion Michelle L (SVP, Clinical Development) | Option Ex | 1,411 | 10.21 | 14,406 |
| 2024-06-05 | Mellion Michelle L (SVP, Clinical Development) | Sale | 7,245 | 18.09 | 131,062 |
| 2024-06-05 | Mellion Michelle L (SVP, Clinical Development) | Option Ex | 7,245 | 10.21 | 73,971 |
| 2024-05-17 | Svenstrup Niels (SVP, Chem. Mfg & Controls) | Sale | 10,000 | 13.41 | 134,100 |
| 2024-02-09 | Shah Rajeev M. (Director) | Buy | 2,557,593 | 10.64 | 27,212,789 |
| 2023-11-30 | Mcarthur James G (President and CEO) | Buy | 1,694 | 4.17 | 7,055 |
| 2023-06-08 | Mcarthur James G (President and CEO) | Sale | 2,381 | 16.04 | 38,188 |
| 2023-06-08 | Mcarthur James G (President and CEO) | Option Ex | 2,381 | 2.71 | 6,452 |
| 2023-06-07 | Mcarthur James G (President and CEO) | Sale | 8,419 | 16.23 | 136,615 |
| 2023-06-07 | Mcarthur James G (President and CEO) | Option Ex | 8,419 | 2.71 | 22,815 |
| 2023-06-06 | Mcarthur James G (President and CEO) | Sale | 18,150 | 16.18 | 293,667 |
| 2023-06-06 | Mcarthur James G (President and CEO) | Option Ex | 18,150 | 2.71 | 49,186 |
| 2023-06-05 | Mcarthur James G (President and CEO) | Sale | 500 | 16.06 | 8,028 |
| 2023-06-05 | Mcarthur James G (President and CEO) | Option Ex | 500 | 2.71 | 1,355 |
| 2023-06-02 | Mcarthur James G (President and CEO) | Sale | 1,800 | 16.04 | 28,863 |
| 2023-06-02 | Mcarthur James G (President and CEO) | Option Ex | 1,800 | 2.71 | 4,878 |
| 2023-03-24 | Goyal Jaya (EVP, Res. & Preclin. Dev.) | Sale | 392 | 20.00 | 7,840 |
| 2023-03-24 | Goyal Jaya (EVP, Res. & Preclin. Dev.) | Option Ex | 392 | 10.88 | 4,264 |
| 2023-02-08 | Goyal Jaya (EVP, Res. & Preclin. Dev.) | Sale | 644 | 17.00 | 10,948 |
| 2023-02-08 | Goyal Jaya (EVP, Res. & Preclin. Dev.) | Option Ex | 644 | 10.88 | 7,006 |
| 2023-02-07 | Goyal Jaya (EVP, Res. & Preclin. Dev.) | Sale | 3,679 | 17.18 | 63,212 |
| 2023-02-07 | Goyal Jaya (EVP, Res. & Preclin. Dev.) | Option Ex | 3,679 | 10.88 | 40,027 |
| 2023-02-06 | Goyal Jaya (EVP, Res. & Preclin. Dev.) | Sale | 1,677 | 17.04 | 28,567 |
| 2023-02-06 | Goyal Jaya (EVP, Res. & Preclin. Dev.) | Option Ex | 1,677 | 10.88 | 18,245 |
| 2022-05-10 | Deerfield Private Design Fund V, L.p. | Buy | 416,666 | 12.00 | 4,999,992 |
| 2022-05-10 | Shah Rajeev M. | Buy | 3,229,200 | 12.00 | 38,750,400 |
Insider trading activities including stock purchases, stock sales, and option exercises of PEPG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pepgen Inc. (symbol PEPG, CIK number 1835597) see the Securities and Exchange Commission (SEC) website.